Home
/
Indivior Pharmaceuticals, Inc.
/
Financials
/
Quarterly
Indivior Pharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Indivior Pharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$314.00M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$302.00M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$266.00M
May 1, 2025
Q3
2025
Sep 30, 2024
$307.00M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$299.00M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$284.00M
May 1, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$42.00M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$18.00M
Jul 31, 2025
Q3
2025
Jun 30, 2025
$18.00M
Oct 30, 2025
Q1
2025
Mar 31, 2025
$47.00M
May 1, 2025
Q2
2025
Mar 31, 2025
$47.00M
Jul 31, 2025
Q3
2025
Mar 31, 2025
$47.00M
Oct 30, 2025
Q1
2025
Dec 31, 2024
$21.00M
May 1, 2025
Q2
2025
Dec 31, 2024
$21.00M
Jul 31, 2025
Q3
2025
Dec 31, 2024
$21.00M
Oct 30, 2025
Q3
2025
Sep 30, 2024
$22.00M
Oct 30, 2025
Q1
2025
Sep 30, 2024
$22.00M
May 1, 2025
Q2
2025
Sep 30, 2024
$22.00M
Jul 31, 2025
Q3
2025
Jun 30, 2024
($97.00M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($97.00M)
Jul 31, 2025
Q1
2025
Jun 30, 2024
($97.00M)
May 1, 2025
Q3
2025
Mar 31, 2024
$61.00M
Oct 30, 2025
Q2
2025
Mar 31, 2024
$61.00M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$61.00M
May 1, 2025
Q3
2025
Dec 31, 2023
($126.00M)
Oct 30, 2025
Q1
2025
Dec 31, 2023
($126.00M)
May 1, 2025
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$43.00M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$72.00M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$66.00M
May 1, 2025
Q1
2025
Dec 31, 2024
$46.00M
May 1, 2025
Q2
2025
Dec 31, 2024
$46.00M
Jul 31, 2025
Q3
2025
Dec 31, 2024
$46.00M
Oct 30, 2025
Q1
2025
Sep 30, 2024
$35.00M
May 1, 2025
Q2
2025
Sep 30, 2024
$35.00M
Jul 31, 2025
Q3
2025
Sep 30, 2024
$35.00M
Oct 30, 2025
Q1
2025
Jun 30, 2024
($118.00M)
May 1, 2025
Q2
2025
Jun 30, 2024
($118.00M)
Jul 31, 2025
Q3
2025
Jun 30, 2024
($118.00M)
Oct 30, 2025
Q2
2025
Mar 31, 2024
$75.00M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$75.00M
May 1, 2025
Q3
2025
Mar 31, 2024
$75.00M
Oct 30, 2025
Q2
2025
Dec 31, 2023
($152.00M)
Jul 31, 2025
Q1
2025
Dec 31, 2023
($152.00M)
May 1, 2025
Q3
2025
Dec 31, 2023
($152.00M)
Oct 30, 2025
Q3
2025
Dec 31, 2022
($77.00M)
Oct 30, 2025
Q1
2025
Dec 31, 2022
($77.00M)
May 1, 2025